Evidence map›Paper›PMID 32157438›Full record

ArticleJournal of cancer research and clinical oncology2020

Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation.

Tilman L R Vogelsang, Elisa Schmoeckel, Christina Kuhn, Thomas Blankenstein, Mina Temelkov, Helene Heidegger, Theresa Maria Kolben, Thomas Kolben, Sven Mahner, Doris Mayr and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prognostic value of long non-coding RNAPathology oncology research : POR · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Tilman L R VogelsangDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Elisa SchmoeckelInstitute of Pathology, Faculty of Medicine, LMU Munich, 80337, Munich, Germany.
Christina KuhnDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Thomas BlankensteinDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Mina TemelkovDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Helene HeideggerDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Theresa Maria KolbenDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Thomas KolbenDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Sven MahnerDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
Doris MayrInstitute of Pathology, Faculty of Medicine, LMU Munich, 80337, Munich, Germany.
Udo JeschkeDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany. udo.jeschke@med.uni-muenchen.de.
Aurelia VattaiDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337, Munich, Germany.
LMU Klinikum · DELudwig-Maximilians-Universität München · DEUniversity Hospital Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLigand-dependent corepressor (LCoR) and receptor-interacting protein 140 (RIP140/NRIP1) play an important role in the regulation of multiple oncogenic signaling pathways and the development of cancer. LCoR and RIP140 form a nuclear complex in breast cancer cells and are of prognostic value in further prostate and cervical cancer. The purpose of this study was to analyze the regulation of these proteins in the development of cervical intraepithelial neoplasia (CIN I-III).

methodsImmunohistochemical analysis was obtained to quantify RIP140 and LCoR expression in formalin-fixed paraffin embedded tissue sections of cervical intraepithelial neoplasia samples. Tissue (n = 94) was collected from patients treated in the Department of Gynecology and Obstetrics, Ludwig-Maximilians-University of Munich, Germany, between 2002 and 2014. Correlations of expression levels with clinical outcome were carried out to assess for prognostic relevance in patients with CIN2 progression. Kruskal-Wallis test and Mann-Whitney U test were used for data analysis.

resultsNuclear LCoR overexpression correlates significantly with CIN II progression. Nuclear RIP140 expression significantly increases and nuclear LCoR expression decreases with higher grading of cervical intraepithelial neoplasia. Cytoplasmic RIP140 expression is significantly higher in CIN III than in CIN I or CIN II.

conclusionA decrease of nuclear LCoR expression in line with an increase of dedifferentiation of CIN can be observed. Nuclear LCoR overexpression correlates with CIN II progression indicating a prognostic value of LCoR in cervical intraepithelial neoplasia. Nuclear and cytoplasmic RIP140 expression increases significantly with higher grading of cervical intraepithelial neoplasia underlining its potential role in the development of pre-cancerous lesions. These findings support the relevance of LCoR and RIP140 in the tumorigenesis indicating a possible role of LCoR and RIP140 as targets for novel therapeutic approaches in cervical intraepithelial neoplasia and cervical cancer.

Indexed as

Cell DedifferentiationBiomarkers, TumorDisease ProgressionFemaleGene Expression Regulation, NeoplasticHumansImmunohistochemistryNeoplasm GradingNuclear Receptor Interacting Protein 1Repressor ProteinsUterine Cervical DysplasiaBiomarkers, TumorLCOR protein, humanNRIP1 protein, humanNuclear Receptor Interacting Protein 1Repressor ProteinsCervical cancerCervical intraepithelial neoplasiaCINLCoRRIP140

Identifiers

PMID32157438
PMCPMC7256097
OpenAlexW3011593149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.